subject: China Unveiled Four New Head Of The Drug Prescription Drug Want To Re-zhenhua Brilliant - China [print this page] Chinese medicine for more than a reorganization in January how the future development, which is a lot of people a hot issue. Yesterday, reform and development in China Pharmaceutical Group, pledging to mobilize Congress, China Pharmaceutical Group Corporation, Chairman, Party Secretary Wang social Ping said, Chinese medicine will be "123" three-step goals to achieve by 2015 Sell Income of 300 million development goals.
Target sales revenue target in 2015 30 billion
"Chinese drug history of New China Medicine Industrial growth in the history of a microcosm. "King of social peace, said, from the Chinese drug situation in reality, not the plant, equipment, technology obsolescence, but thought the old, old concept, sense of old; not a lack of talent, technology, and not a lack of management, lack of funds, the key is lack of motivation, lack of confidence. We need the whole group to conduct the "emancipating the mind, re-Zhenhua medicine" great debate, for the Chinese medicine a strong impetus to the reform and development. He said, after the reorganization, the development of Chinese medicine strategy is to "co-ordinate integration, advocated innovation, optimization and upgrading, so refined and stronger." Chinese medicine's development objective is to implement the "three steps" to achieve "January 23" target. the first step to sales revenue in 2011 reached 10 billion element; the second step, to 2013 sales revenue of 200 billion yuan; the third step, to 2015 sales revenue reached 30 billion yuan.
"Of Hebei Medical Industry Adjustment and Development Plan" put forward: By 2011, the province's pharmaceutical enterprises above designated size reached 50 billion yuan sales income; to 2013, sales income reached 70 billion yuan, to double, to me Chinese province province into the country. Ping Wang agency said, "By 2013, annual sales income of 200 foster billion large multinational enterprise group 2, the two of them, Chinese medicine will be one or the other."
Measures For 4 prescription drug brilliant re Zhenhua
Generous in the ambitious plan the future development of Chinese medicine at the same time, Wang social level how Chinese medicine for the grand blueprint into reality presented four prescriptions.
Prescription 1: The strategic restructuring of enterprises
"Chinese medicine will vigorously implement the strategic restructuring of enterprises to comprehensively improve the quality of the development of China Pharmaceutical Group." Wang Ping said society, Chinese medicine will be the overall relocation as an opportunity to demonstrate and optimize a number of good market prospects and development potential, with intensive international and domestic competitiveness of scale and large projects, the scientific rational distribution of production. Secondly, to improve the capacity to adjust equity structure will completely solve the "set instead of groups, Qin and Han dynasties, their own way," the outstanding issues; with the exception of the joint venture, the Group and a subsidiary stock company subsidiary, must become a wholly-owned listed companies subsidiaries or branches, to achieve overall maximum benefit. Products, processes behind long-term huge losses, losses hopeless units, to decisively shut down, eliminating losses.
Prescription 2: To create high-capital operation platform
Chinese medicine to create high-capital operation platform to build a virtuous circle of capital financing system. First of all, we must optimize the capital structure; also expand financing channels, in the capital markets for financing; Chinese medicine will advance the future listing of the primary sector as a whole, efforts to improve the quality of listed companies on assets and promote the integration of advanced production capabilities; grasp the strategic initiative to attract investment to further expand Cooperation In the field, not only bring in capital, but also with famous research institutes, large pharmaceutical companies in the world to establish strategic cooperative relations.
Prescription 3: Technological innovation to create leading products
R & D in science and technology, to speed up the building to meet the market demand for "research" science and technology innovation system, the limited technology resources to the sustainable development of China Pharmaceutical Group up, the enzyme , ampicillin, Cephalosporin 4, 6 and a number of cephalosporin with strong market competitiveness of leading products, truly China Pharmaceutical Group into a leading, world-renowned medical technology thriving enterprise.
